BIO-TECHNE Corp
TECH· Nasdaq
TECHBIO-TECHNE Corp
Filed Aug 24, 2022 · 10-K · 55 days after period end · 0001558370-22-013935
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020 | Q4 2019 |
|---|---|---|---|---|
| Revenue | $288.23M | $259.03M | $175.83M | $191.66M |
| Net Income | $61.52M | $14.96M | $58.85M | $16.46M |
| EPS Diluted | — | — | $1.48 | $0.42 |
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Jun 30, 2022 · filed Aug 24, 2022 · 55 d after period end
